Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new version entry on 2025-11-21 adds a 'Study Status' section with revision v3.3.2, and the prior revision v3.2.0 was removed on 2025-06-12.
    Difference
    0.4%
    Check dated 2025-11-25T11:52:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page history shows the removal of a government funding notice that warned about potential delays and downtime. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:16:59.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No substantive changes to the study status, eligibility, or record history are evident between the old and new screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:20:44.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government funding notice about possible delays and status, and updated operating details for the NIH Clinical Center; - Updated version to v3.2.0; - Removed the previous version label v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T07:50:09.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-29T03:55:16.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No core content, pricing, stock, or other substantive information was changed.
    Difference
    0.7%
    Check dated 2025-09-14T21:38:25.000Z thumbnail image

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.